HIREPA 1 (Repaglinide (1mg))

Hirepa 1mg Tablet is indicated for the management of elevated blood sugar levels in adults diagnosed with type 2 diabetes mellitus. This medication is often prescribed in conjunction with other antidiabetic agents to help achieve optimal glycemic control. It plays a critical role in reducing the risk of severe diabetic complications, including renal impairment and vision loss. Typically, Hirepa is utilized when lifestyle modifications such as dietary changes and exercise, alongside other medications, have proven insufficient for blood sugar management. For optimal efficacy, it is recommended to take this tablet prior to meals, with the dosage tailored to individual health conditions and glucose readings, adhering to your healthcare provider’s guidance. Consistent daily intake of Hirepa at the same time enhances its effectiveness, and discontinuation should only occur upon medical advice. Maintaining adherence to a prescribed dietary and fitness regimen is essential while using this medication, as these lifestyle factors significantly influence diabetes management. The most prevalent adverse effect associated with Hirepa is hypoglycemia, or low blood sugar. To mitigate this risk, carrying a source of sugar or glucose tablets is advisable. Other potential side effects may include abdominal discomfort, sinus inflammation, joint and back pain, nausea, and diarrhea. Should these effects cause concern or persist, it is important to consult a healthcare professional.